These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2446492)

  • 1. Immunocytochemical identification of cells in serous effusions. Technical considerations.
    Li CY; Lazcano-Villareal O; Pierre RV; Yam LT
    Am J Clin Pathol; 1987 Dec; 88(6):696-706. PubMed ID: 2446492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of a pool of monoclonal antibodies in diagnosing cells from serous cavities.
    Cappellari A; Bagarella M; Ménard S; Calabrese M; Colnaghi MI
    Tumori; 1993 Jun; 79(3):211-3. PubMed ID: 8236507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic accuracy of the immunocytochemical study of body fluids.
    Li CY; Ziesmer SC; Wong YC; Yam LT
    Acta Cytol; 1989; 33(5):667-73. PubMed ID: 2675517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunocytochemical staining of cells in pleural and peritoneal effusions with a panel of monoclonal antibodies.
    Ghosh AK; Spriggs AI; Taylor-Papadimitriou J; Mason DY
    J Clin Pathol; 1983 Oct; 36(10):1154-64. PubMed ID: 6194183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunocytochemical staining with monoclonal antibodies in cytologically "negative" serous effusions from patients with malignant disease.
    Ghosh AK; Mason DY; Spriggs AI
    J Clin Pathol; 1983 Oct; 36(10):1150-3. PubMed ID: 6194182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indirect immunoalkaline phosphatase staining of cytologic smears of serous effusions for tumor marker studies.
    To A; Dearnaley DP; Ormerod MG; Canti G; Coleman DV
    Acta Cytol; 1983; 27(2):109-13. PubMed ID: 6188304
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunocytochemical reaction of Ca1 and HMFG2 monoclonal antibodies with cells from serous effusions.
    Singer S; Boddington MM; Hudson EA
    J Clin Pathol; 1985 Feb; 38(2):180-4. PubMed ID: 3881482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of selected lineage-directed antibodies useful in routinely processed tissues.
    Corwin DJ; Gown AM
    Arch Pathol Lab Med; 1989 Jun; 113(6):645-52. PubMed ID: 2471485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new marker for human cancer cells. 3. Immunocytochemical detection of malignant cells in serous fluids with the Ca1 antibody.
    Woods JC; Spriggs AI; Harris H; McGee JO
    Lancet; 1982 Sep; 2(8297):512-4. PubMed ID: 6125677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to intermediate filaments in surgical pathology.
    Lehto VP; Miettinen M; Virtanen I
    Arch Geschwulstforsch; 1986; 56(4):283-98. PubMed ID: 2428329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncofetal antigens as tumor markers in the cytologic diagnosis of effusions.
    Orell SR; Dowling KD
    Acta Cytol; 1983; 27(6):625-9. PubMed ID: 6196931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of two epithelium-specific monoclonal antibodies for diagnosis of malignancy in serous effusions.
    Epenetos AA; Canti G; Taylor-Papadimitriou J; Curling M; Bodmer WF
    Lancet; 1982 Nov; 2(8306):1004-6. PubMed ID: 6127499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytologic diagnosis of melanoma in serous effusions. A morphologic and immunocytochemical study.
    Longatto Filho A; de Carvalho LV; Santos Gda C; Oyafuso MS; Lombardo V; Bortolan J; Neves JI
    Acta Cytol; 1995; 39(3):481-4. PubMed ID: 7762336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical localization of prekeratin filaments in benign and malignant cells in effusions. Comparison with intermediate filament distribution by electron microscopy.
    Kahn HJ; Hanna W; Yeger H; Baumal R
    Am J Pathol; 1982 Nov; 109(2):206-14. PubMed ID: 6182803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunocytochemical detection of ovarian carcinoma cells in serous effusions.
    Cuijpers VM; Boerman OC; Salet van de Pol MR; Vooijs GP; Poels LG; Ramaekers FC
    Acta Cytol; 1993; 37(3):272-9. PubMed ID: 8498129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnostic cytology of serous effusions (author's transl)].
    Djelali D
    Ther Umsch; 1973 Aug; 30(8):611-7. PubMed ID: 4751584
    [No Abstract]   [Full Text] [Related]  

  • 17. Value of BCA-225 in the cytologic diagnosis of malignant effusions: an immunocytochemical study of 197 cases.
    Loy TS; Diaz-Arias AA; Bickel JT
    Mod Pathol; 1990 May; 3(3):294-7. PubMed ID: 2194212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunocytochemistry in the differential diagnosis of serous effusions: a comparative evaluation of eight monoclonal antibodies in Papanicolaou stained smears.
    Lozano MD; Panizo A; Toledo GR; Sola JJ; Pardo-Mindán J
    Cancer; 2001 Feb; 93(1):68-72. PubMed ID: 11241268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Contribution of immunocytochemical marking of benign cells to the diagnosis of serous effusions].
    Gaulier A; Cava E; Chosia MC; Pore G; Marsan C
    Ann Pathol; 1986; 6(4-5):323-8. PubMed ID: 3814272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of reactivity of four novel monoclonal antibodies (B72.3, DF3, B1.1 and B6.2) with cells in human malignant and benign effusions.
    Szpak CA; Johnston WW; Lottich SC; Kufe D; Thor A; Schlom J
    Acta Cytol; 1984; 28(4):356-67. PubMed ID: 6205527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.